# VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML

> **NCT07635485** · NA · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 50 (estimated)

## Conditions studied

- Hypoplastic Acute Myeloid Leukemia
- Secondary AML (Adult)

## Interventions

- **DRUG:** Venetoclax (VEN)
- **DRUG:** Azacitidine (AZA)
- **PROCEDURE:** Allo-HSCT

## Key facts

- **NCT ID:** NCT07635485
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2029-05-31
- **Final completion:** 2029-08-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-06-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07635485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07635485, "VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07635485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*